Department of Neuropsychiatry, University of Birmingham and BSMHFT, Birmingham, UK.
Ther Adv Neurol Disord. 2011 Jan;4(1):25-45. doi: 10.1177/1756285610390261.
TOURETTE SYNDROME (TS) IS A CHRONIC NEURODEVELOPMENTAL DISORDER CHARACTERIZED BY TICS: repetitive, involuntary movements and vocalizations. These symptoms can have a significant impact on patients' daily functioning across many domains. Tics tend to be most severe in child and adolescent sufferers, so their presence has the potential to impact a period of life that is both critical for learning and is often associated with the experience of greater social tension and self-consciousness than adulthood. Furthermore, control over tics that lead to physical impairment or self-injurious behaviour is of vital importance in maintaining health and quality of life. There are numerous complicating factors in the prescription of treatment for tics, due to both the side effects associated with alleviating agents and patient characteristics, such as age and comorbid conditions. This review summarizes literature pertaining to the efficacy and safety of both traditionally prescribed and more modern medications. We also discuss the merits of behavioural and surgical techniques and highlight newer emerging treatments. Although treatment response is to some extent variable, there are a number of agents that are clearly useful as first-line treatments for TS. Other interventions may be of most benefit to patients exhibiting refractory tics or more specific symptom profiles.
妥瑞氏症候群(TS)是一种慢性神经发育障碍,其特征为抽搐:重复、无意识的运动和发声。这些症状会对患者在多个领域的日常功能产生重大影响。抽搐在儿童和青少年患者中最为严重,因此它们的存在有可能会影响一个对于学习至关重要的时期,并且往往与比成年时期更大的社会紧张感和自我意识相关联。此外,对于导致身体损伤或自伤行为的抽搐进行控制,对于维持健康和生活质量至关重要。由于缓解剂相关的副作用以及患者的特征(如年龄和合并症),在为抽搐症开处方治疗时存在许多复杂的因素。本综述总结了与传统处方和更现代药物相关的疗效和安全性的文献。我们还讨论了行为和手术技术的优点,并强调了新出现的治疗方法。尽管治疗反应在某种程度上是可变的,但有许多药物显然可作为 TS 的一线治疗药物。对于表现出难治性抽搐或更具体症状谱的患者,其他干预措施可能更有益。